Keyphrases
Catalonia
100%
Spain
82%
Primary Immunodeficiency
69%
COVID-19
63%
Newborn Screening
49%
Pediatric Patients
48%
Pediatric
47%
AIDS/HIV
39%
Severe Combined Immunodeficiency
38%
Inflammation
34%
Barcelona
32%
T-cell Receptor Excision Circles
31%
Polymerase Chain Reaction
28%
T Cells
26%
Cytomegalovirus Infection
26%
Europe
24%
Multisystem Inflammatory Syndrome in children (MIS-C)
24%
Cytomegalovirus
23%
Hospitalization
22%
Inborn Errors of Immunity
22%
Clinical Outcomes
21%
HIV-infected children
21%
Odds Ratio
20%
Confidence Interval
20%
Immunodeficiency
20%
Virus
19%
Zika Virus
19%
Array Comparative Genomic Hybridization (aCGH)
18%
Dried Blood Spots
18%
Infected children
17%
Hebron
17%
Antiretroviral
16%
Quantitative PCR
16%
Zika Virus Infection
16%
At Birth
16%
Pediatric Population
16%
Metabolic Syndrome
16%
Hyperlactatemia
16%
Complement Factors
16%
Neonatal Screening
16%
Human Immunodeficiency Virus Type 1 (HIV-1)
16%
Autoinflammatory
16%
Imported Diseases
16%
Acute Lower Respiratory Tract Infection
16%
Universal Newborn Screening
16%
Off-label Use
16%
Surgical Wound Infection
16%
Clinical Impact
16%
Type I Interferon
16%
Tertiary Hospital
16%
Medicine and Dentistry
Human Immunodeficiency Virus
83%
Pediatrics
67%
Infection
52%
Pediatrics Patient
47%
Newborn Screening
41%
Diseases
39%
Adolescence
29%
Polymerase Chain Reaction
28%
COVID-19
27%
Severe Combined Immunodeficiency
27%
Immune Deficiency
27%
Zika Virus
24%
Serositis
24%
Dried Blood Spot
22%
Cytomegalovirus
22%
T Lymphocyte Receptor
21%
Retrospective Study
20%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
Screening
20%
Intensive Care
18%
Congenital Cytomegalovirus Infection
17%
Odds Ratio
16%
Off-Label Use
16%
Humoral Immune Deficiency
16%
Metabolic Syndrome
16%
Human Cytomegalovirus
16%
Zika Fever
16%
Heart Surgery
16%
Surgical Infection
16%
Meningitis
15%
Bronchiolitis
14%
Real Time Polymerase Chain Reaction
13%
Neonatal Infant
13%
Cytomegalovirus Infection
13%
Clinical Trial
13%
Early Diagnosis
12%
T Lymphocyte
12%
Human Respiratory Syncytial Virus
12%
Pneumococcal Infection
12%
Immigrant
11%
Streptococcus Pneumonia
11%
Prevalence
11%
Antiinfective Agent
11%
Human Immunodeficiency Virus Infection
10%
Hematology
10%
Infection Control
10%
Epidemiological Surveillance
10%
Intensive Care Unit
9%
Bacterial Infection
9%
Pneumococcal Pneumonia
9%
Immunology and Microbiology
Human Immunodeficiency Virus
69%
Immunodeficiency
59%
T Cell
32%
Adolescence
31%
COVID-19
30%
T-Cell Receptor Excision Circles
29%
Prevalence
29%
Newborn Screening
24%
Severe Combined Immunodeficiency
18%
Array Comparative Genomic Hybridization
17%
B Cell
17%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Chromosome 4
16%
DNA Methylation
16%
Human Immunodeficiency Virus 1
16%
Autoantibodies
16%
Interferon Type I
16%
Screening
16%
Immunoglobulin A
16%
Common Variable Immunodeficiency
16%
CD4
13%
Primary Immunodeficiency
12%
Exon
12%
Cytotoxic T-Cell
12%
Humoral Immune Deficiency
12%
TLR3
12%
Autoinflammatory Syndromes
12%
Regulatory T Cell
11%
Haploinsufficiency
11%
Immunopathology
10%
Cell Population
10%
Whole Exome Sequencing
10%
Influenza
10%
Human Immunodeficiency Virus Infection
9%
Kawasaki Disease
9%
Autosomal Recessive Inheritance
9%
Reference Value
9%
Chronic Granulomatous Disease
9%
Autoimmunity
8%
Viral Load
8%
Ataxia Telangiectasia
8%
Dynamics
8%
Complement System
8%
Cytokine
8%
Autoimmune Lymphoproliferative Syndrome
8%
Uniparental Disomy
8%
Kidney Function
8%
Lower Respiratory Tract
8%
Pneumocystis Jiroveci
8%
Pathogenicity
8%
